DNAJB4 and cancer: However, among the patients with late-stage cancer, high DNAJB4 expression was significantly associated with increased levels of caspase-3 (OR: 1.20, p = 0.013), CD31 (OR: 1.06, p = 0.004), and EphA5 (OR: 1.04, p = 0.033), but it was negatively correlated with E-cad expression (OR: 0.93, p = 0.011) (Table 4B).